Literature DB >> 11536156

A molecular chart of thymocyte positive selection.

M Correia-Neves1, D Mathis, C Benoist.   

Abstract

As a new slant on T lymphocyte repertoire selection, we have examined batteries of TCR sequences in thymi from transgenic mice engineered to exhibit limited, focussed TCR diversity. We have tracked the fate of differentiating thymocytes expressing a set of particular TCR through the positive selection process. Subtly different TCR sequences can promote different maturation pathways and commitment choices. Two distinct routes are followed by CD8-lineage cells interacting with MHC class I molecules, via TCR(hi) CD4(+)CD8(+) or CD4(+)CD8(int) intermediates, while CD4-lineage cells mature exclusively via a CD4(+)CD8(int) stage. The CD8-lineage routes are partially exclusive, indicating that the latter cell type is not always preceded by the former. The distribution of sequences also indicates that CD4 / CD8-lineage commitment is not strictly correlated with the class of MHC molecule engaged, and that some mechanism prevents mismatched intermediates from achieving full maturity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11536156     DOI: 10.1002/1521-4141(200109)31:9<2583::aid-immu2583>3.0.co;2-z

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  Activated Notch2 potentiates CD8 lineage maturation and promotes the selective development of B1 B cells.

Authors:  Colleen M Witt; Vincent Hurez; C Scott Swindle; Yoshio Hamada; Christopher A Klug
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

Review 2.  The many roles of TOX in the immune system.

Authors:  Parinaz Aliahmad; Akop Seksenyan; Jonathan Kaye
Journal:  Curr Opin Immunol       Date:  2011-12-30       Impact factor: 7.486

3.  Development of CD4+ T cells expressing a nominally MHC class I-restricted T cell receptor by two different mechanisms.

Authors:  Qing Ge; Phillip D Holler; Vinay S Mahajan; Tam Nuygen; Herman N Eisen; Jianzhu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-27       Impact factor: 11.205

Review 4.  The TOX subfamily: all-round players in the immune system.

Authors:  Jiawen Han; Minjie Wan; Zhanchuan Ma; Ping He
Journal:  Clin Exp Immunol       Date:  2022-06-23       Impact factor: 5.732

Review 5.  TOX gene: a novel target for human cancer gene therapy.

Authors:  Xin Yu; Zheng Li
Journal:  Am J Cancer Res       Date:  2015-11-15       Impact factor: 6.166

6.  Expression of 4-1BB and 4-1BBL in thymocytes during thymus regeneration.

Authors:  Young-Mi Kim; Hye Kyung Kim; Hyo Jin Kim; Hee-Woo Lee; Seong-A Ju; Beom K Choi; Byoung S Kwon; Bong-Seon Kim; Jae-Bong Kim; Young-Tak Lim; Sik Yoon
Journal:  Exp Mol Med       Date:  2009-12-31       Impact factor: 8.718

7.  Dynamic repositioning of CD4 and CD8 genes during T cell development.

Authors:  Stephanie Delaire; Yina Hsing Huang; Shaio Wei Chan; Ellen A Robey
Journal:  J Exp Med       Date:  2004-12-06       Impact factor: 14.307

8.  Low ligand requirement for deletion and lack of synapses in positive selection enforce the gauntlet of thymic T cell maturation.

Authors:  Peter J R Ebert; Lauren I Richie Ehrlich; Mark M Davis
Journal:  Immunity       Date:  2008-11-14       Impact factor: 31.745

9.  Development of all CD4 T lineages requires nuclear factor TOX.

Authors:  Parinaz Aliahmad; Jonathan Kaye
Journal:  J Exp Med       Date:  2008-01-14       Impact factor: 14.307

10.  Unraveling a revealing paradox: Why major histocompatibility complex I-signaled thymocytes "paradoxically" appear as CD4+8lo transitional cells during positive selection of CD8+ T cells.

Authors:  Remy Bosselut; Terry I Guinter; Susan O Sharrow; Alfred Singer
Journal:  J Exp Med       Date:  2003-06-16       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.